Arkolith/Insider Trading/KRTX/Form 4

Miller Andrew Craig

President of R&DKaruna Therapeutics, Inc. (KRTX) · full profile →Form 4 · filed Mar 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
2 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)9K$330.00$3.1M0
Mar 18, 2024Disposed to issuer(D)14K$330.00$4.6M9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)73K$218.03$16.0M0
Mar 18, 2024Disposed to issuer(D)25K$142.74$3.6M0
Mar 18, 2024Disposed to issuer(D)16K$330.00$5.2M0
Mar 18, 2024Disposed to issuer(D)48K$327.08$15.6M0
Mar 18, 2024Disposed to issuer(D)12K$322.73$3.7M0
Mar 18, 2024Disposed to issuer(D)232K$320.80$74.4M0
Mar 18, 2024Disposed to issuer(D)70K$230.28$16.1M0
Mar 18, 2024Disposed to issuer(D)67K$198.36$13.3M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-013930) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML